Schedule 13G ownership disclosure

AVADEL PHARMACEUTICALS PLC

Common Stock · CUSIP: G29687103

Event date: 2025-09-30

Filing-level shares
7,429,718
Percent of class
7.7%
  • JANUS HENDERSON GROUP PLC

    Shares: 7,429,718 · Class: 7.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000300
Form type
SCHEDULE 13G/A
Filer
AVADEL PHARMACEUTICALS PLC
CIK
CIK 1012477
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub